Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$117 |
Successful A$15 Million Placement To Accelerate Growth
|
2 Jun 2025 9:22AM |
$0.480 |
$0.595 |
risen by
23.96%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Golden Horse Minerals Limited (GHM) completed a A$15 million placement.
- Placement was strongly supported by institutional and sophisticated investors.
- Funds will be used for exploration and development of flagship projects.
- The capital enables accelerated drilling and resource expansion.
- Proceeds will also provide flexibility for future acquisitions.
- Placement reflects strong investor confidence in GHM’s strategic direction.
- Funds will be used to fast-track development and deliver shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Viva Energy Group Limited (VEA) ORDINARY FULLY PAID |
Energy |
$3,084 |
Initial Director's Interest Notice - John Joyce
|
2 Jun 2025 9:22AM |
$1.870 |
$1.910 |
risen by
2.14%
|
|
VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$443 |
Weekly NTA Update
|
2 Jun 2025 9:22AM |
$1.610 |
$1.790 |
risen by
11.18%
|
|
Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$82 |
Final Director's Interest Notice - Anne Ward
|
2 Jun 2025 9:21AM |
$0.145 |
$0.280 |
risen by
93.10%
|
|
Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,776 |
Final Director's Interest Notice - Samantha Lewis
|
2 Jun 2025 9:21AM |
$1.615 |
$1.120 |
fallen by
30.65%
|
|
VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$443 |
Update - Notification of buy-back - VG1
|
2 Jun 2025 9:20AM |
$1.610 |
$1.790 |
risen by
11.18%
|
|
360 Capital Group (TGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$59 |
Update - Notification of buy-back - TGP
|
2 Jun 2025 9:20AM |
$0.655 |
$0.300 |
fallen by
54.20%
|
|
EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$31 |
EVR Agrees to Sell Yanamina Gold Project in Peru for US$6m
|
2 Jun 2025 9:19AM |
$0.005 |
$0.014 |
risen by
180%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- EV Resources Limited (EVR) has agreed to sell its Yanamina Gold Project in Peru to Kiwanda S.A.C. for US$6 million.
- The sale aligns with EVR's strategy to focus on its core lithium exploration and development assets.
- The agreement includes a 60-day due diligence period and staged payment structure.
- An initial non-refundable payment is to be made by Kiwanda S.A.C. upon execution of the agreement.
- Completion of the sale is subject to satisfaction of certain conditions precedent.
- Funds raised from the transaction will provide additional working capital for EVR.
- The sale allows EVR to streamline its portfolio and focus resources on its principal lithium operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$20 |
Positive Human PK Study Results for NTI164
|
2 Jun 2025 9:19AM |
$0.021 |
$0.019 |
fallen by
9.52%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech International Limited completed first-in-human PK study for NTI164.
- Study conducted in healthy adult volunteers.
- NTI164 was found to be safe and well-tolerated.
- No serious adverse events were reported.
- PK results demonstrate predictable and dose-proportional plasma concentrations.
- Results support continued development of NTI164 for neurological and neuropsychiatric indications.
- Data provides a foundation for future clinical studies in patient populations.
- The announcement strengthens NTI164’s clinical development profile and commercial potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$82 |
Final Director's Interest Notice - Ben Heap
|
2 Jun 2025 9:19AM |
$0.145 |
$0.280 |
risen by
93.10%
|
|
Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,167 |
Update - Notification of buy-back - KAR
|
2 Jun 2025 9:18AM |
$1.665 |
$1.595 |
fallen by
4.20%
|
|
BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$10 |
BSA Leadership Transition and Business Update
|
2 Jun 2025 9:18AM |
$0.065 |
$0.130 |
risen by
100%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Simon Moore, Chair of BSA Limited, will become Executive Chair effective 31 December 2023.
- Current CEO Mark Lowe will depart from BSA Limited at the end of December 2023.
- BSA is conducting a search for a new CEO.
- The company will focus on core technical services, especially in telecommunications and energy infrastructure.
- BSA will exit non-core operations and streamline its business.
- A review of the group’s cost base and structure is underway to align with market conditions.
- Operational improvements have been implemented to address recent trading performance.
- The business update acknowledges challenging market conditions.
- Further updates on the transformation and leadership transition will be provided in due course.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$368 |
Update on US legal proceeding with TherapeuticsMD Inc
|
2 Jun 2025 9:18AM |
$4.950 |
$4.530 |
fallen by
8.48%
|
|
Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$66 |
Proposed issue of securities - GCM
|
2 Jun 2025 9:18AM |
$0.015 |
$0.025 |
risen by
66.67%
|
|
Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$66 |
Proposed issue of securities - GCM
|
2 Jun 2025 9:17AM |
$0.015 |
$0.025 |
risen by
66.67%
|
|
Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$66 |
$7M Institutional Placement to Advance VHD to First Revenue
|
2 Jun 2025 9:17AM |
$0.015 |
$0.025 |
risen by
66.67%
|
|
GCM - Price-sensitive ASX Announcement
Full Release
Key Points
- GCM raised $7 million through an institutional placement to fast-track the Vittangi High-Grade Graphite Deposit (VHD).
- The fundraising was well supported by new and existing institutional investors.
- Funds will be used for resource expansion drilling, feasibility studies, environmental work, offtake agreements, and early stage project activities.
- The VHD project is central to GCM’s strategy to supply high-purity graphite to lithium-ion battery and critical industries.
- GCM aims to align with global trends in decarbonization and electrification.
- Leadership emphasized the placement’s importance for advancing VHD towards first revenue and establishing GCM as a key player in critical minerals.
- The placement strengthens GCM’s financial position for project development and resource expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$35 |
Trading Halt
|
2 Jun 2025 9:17AM |
$0.051 |
$0.092 |
risen by
80.39%
|
|
QFE - Price-sensitive ASX Announcement
Full Release
Key Points
- QuickFee Limited requested a trading halt on its securities on 22 November 2022.
- The trading halt is pending an announcement about a capital raising.
- The halt will be in place until Thursday, 24 November 2022 or an earlier announcement.
- The trading halt aims to ensure disclosure of sensitive information and an orderly market.
- Further details regarding the capital raising will be provided in the upcoming announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$75 |
Update - Notification of buy-back - PCG
|
2 Jun 2025 9:15AM |
$0.790 |
$0.755 |
fallen by
4.43%
|
|
Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,901 |
Update - Notification of buy-back - GNC
|
2 Jun 2025 9:15AM |
$7.680 |
$8.550 |
risen by
11.33%
|
|
Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$68 |
Trading Halt
|
2 Jun 2025 9:15AM |
$0.044 |
$0.031 |
fallen by
29.55%
|
|
ESR - Price-sensitive ASX Announcement
Full Release
Key Points
- Estrella Resources Limited requests a trading halt effective 13 June 2023.
- The trading halt is pending an announcement related to a proposed capital raising.
- The halt will end when the announcement is made or at the start of trading on 15 June 2023, whichever is earlier.
- The trading halt is intended to manage disclosure obligations and ensure an informed market.
- The ASX has been requested to grant the trading halt in accordance with Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$73 |
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data
|
2 Jun 2025 9:14AM |
$0.024 |
$0.031 |
risen by
29.17%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited announced positive preclinical data for its Lu177-B7H3-mAb radiotherapeutic program.
- Preclinical studies demonstrated significant anti-tumor activity of the Lu177-B7H3-mAb in relevant models.
- The therapy exhibited a favorable safety profile in tested preclinical settings.
- B7-H3 is an important target for tumors with high unmet medical needs.
- Preclinical evidence supports progression toward clinical development.
- The announcement reinforces RAD's strategic focus on expanding its targeted radiopharmaceutical pipeline.
- Results position the company for discussions with regulatory authorities and future clinical trials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Quinton Oswald
|
2 Jun 2025 9:14AM |
$0.600 |
$0.600 |
fallen by
0%
|
|
AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$345 |
Weekly Estimated NTA as at 30 May 2025
|
2 Jun 2025 9:13AM |
$1.090 |
$1.075 |
fallen by
1.38%
|
|
Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Dr Susan Orr
|
2 Jun 2025 9:13AM |
$0.600 |
$0.600 |
fallen by
0%
|
|
Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Dr Julia Haller
|
2 Jun 2025 9:13AM |
$0.600 |
$0.600 |
fallen by
0%
|
|